Status COVID-19/Flu A&B Rapid Antigen Test (33225) Flu A&B Recognized and trusted brand globally

Recognized and trusted brand globally

90% - Nasal/nasopharyngeal wash PPV* 56% - Nasopharyngeal swab

Collections are observed

Single-use Cartridge for the qualitative detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)* Point-of-care (POC) molecular PCR testing for Chlamydia and Gonorrhea in both male and female patients* 30-minute time to result* Single-visit “test and treat”* FDA-cleared and CLIA-waived* Fully-automated* Integrates with EMR/LIS* Clear detected/not detected results* Accuracy:FEMALE Chlamydia: Sensitivity 96

Status COVID-19/Flu A&B Rapid Antigen Test (33225) Flu A&B Recognized and trusted brand globallyStatus COVID 19 Flu A&B test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS CoV 2, influenza A and or influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID 19 by their healthcare provider, within the first five days of onset of symptoms. Product